Login

Mr. Nitin Verma, CEO of Mirae Asset Global Indices, unveils the future of ETFs at Innowave. 00:10:00

Share On Facebook Share On Twitter

Kim, Mi Seob · President & CEO, Mirae Asset Global Investments

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Ed Bastian, CEO of Delta Air Lines, focuses on enhancing the travel experience by making it more seamless and enjoyable for passengers.
00:10:00
Unisys Corp Chairman and CEO Peter Altabef discusses the company's 147-year history and its 96 years on the NYSE.
00:10:00
Strategic Private Investments in Global Emerging Markets
00:10:00
Thasunda Brown Duckett: A Journey of Resilience and Leadership | Thasunda Brown Duckett, CEO , TIAA.
00:10:00
Optimizing 529 Plans for College Savings | Derek Jess, CFP®, Senior Wealth Manager at Plancorp Wealth Management
00:10:00
Susan Rubin Suleiman discusses her memoir "Daughter of History" and her connection to Budapest, Hungary.|Susan Suleiman,Professor,Harvard University
00:10:00
Trilogy Metals: Advancing High-Grade Copper Projects in Alaska with Key Developments and Strategic Partnerships
00:10:00
Alexandre Birman on Arezzo's Ambitious Growth Plans for the Year | Alexandre Birman, CEO, Arezzo Industria e Comercio SA.
00:00:00
Malignancy-Associated High-Risk Pulmonary Embolism - Dr. Ramy Sedhom, a Cardiology Fellow
00:10:00
Keno Hill Silver District Development and Production Update
00:10:00
Vietnam's Offshore Wind Potential: A Prime Opportunity for Development and Success | Markus Lesser, CEO , PNE AG .
00:10:00
banpu 2q2012 | Sinon Vongkusolkit, CEO, Banpu PCLBANPU:SET

© 2017 - Neuhu+